相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microbial platform technology for recombinant antibody fragment production: A review
Sanjeev Kumar Gupta et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2017)
A Recombinant Human Anti-Platelet scFv Antibody Produced in Pichia pastoris for Atheroma Targeting
Amelie Vallet-Courbin et al.
PLOS ONE (2017)
Expression and characterization of recombinant humanized anti-HER2 single-chain antibody in Pichia pastoris for targeted cancer therapy
Xiaodan Cao et al.
BIOTECHNOLOGY LETTERS (2015)
Refolded scFv Antibody Fragment against Myoglobin Shows Rapid Reaction Kinetics
Hyung-Nam Song et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Immunotherapy for Alzheimer's disease: past, present and future
Brian Spencer et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Refolding Technologies for Antibody Fragments
Tsutomu Arakawa et al.
ANTIBODIES (2014)
Elongation of the C-terminal domain of an anti-amyloid β single-chain variable fragment increases its thermodynamic stability and decreases its aggregation tendency
Geovanny Rivera-Hernandez et al.
MABS (2013)
Loss of deep cerebellar nuclei neurons in the 3xTg-AD mice and protection by an anti-amyloid β antibody fragment
Gisela Esquerda-Canals et al.
MABS (2013)
Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of alzheimer disease
Lydia Gimenez-Llort et al.
MABS (2013)
An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway
Marta Marin-Argany et al.
BIOCHEMICAL JOURNAL (2011)
Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction
Jennifer L. Tomic et al.
NEUROBIOLOGY OF DISEASE (2009)
A beta Oligomers - a decade of discovery
Dominic M. Walsh et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Antibody production
John R. Birch et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Expression, purification, and in vitro refolding of a humanized single-chain Fv antibody against human CTLA4 (CD152)
LH Chen et al.
PROTEIN EXPRESSION AND PURIFICATION (2006)
Expression of heterologous proteins in Pichia pastoris:: a useful experimental tool in protein engineering and production
R Daly et al.
JOURNAL OF MOLECULAR RECOGNITION (2005)
Engineered antibody fragments and the rise of single domains
P Holliger et al.
NATURE BIOTECHNOLOGY (2005)
Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition
DM Wilcock et al.
JOURNAL OF NEUROSCIENCE (2004)
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
JM Orgogozo et al.
NEUROLOGY (2003)
Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease
C Hock et al.
NEURON (2003)
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide:: a case report
JAR Nicoll et al.
NATURE MEDICINE (2003)
Immunotherapy: past, present and future
TA Waldmann
NATURE MEDICINE (2003)
Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology
F Bard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Endotoxin removal from protein solutions
D Petsch et al.
JOURNAL OF BIOTECHNOLOGY (2000)
分享论文
